OverviewSuggest Edit

Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer. It offers oncolytic virus therapies, utilizing engineered viruses designed to target ovarian cancer, glioblastoma, mesothelioma, head and neck cancer, blood cancers, endometrial cancer, hematologic malignancies and, multiple myeloma and gastrointestinal cancer.
TypePrivate
Founded2016
HQRochester, MN, US
Websitevyriad.com

Latest Updates

Employees (est.) (Sept 2021)36(+6%)
Cybersecurity ratingAMore

Key People/Management at Vyriad

Stephen J. Russell

Stephen J. Russell

President and Chief Executive Officer, Director
Edwin Kania

Edwin Kania

Chairman
Kah-Whye Peng

Kah-Whye Peng

Chief Technical Officer
Nathan Stacy

Nathan Stacy

Director
Alice S. Bexon

Alice S. Bexon

Chief Medical Officer
Jim Hannon

Jim Hannon

Chief Financial Officer
Show more

Vyriad Office Locations

Vyriad has an office in Rochester
Rochester, MN, US (HQ)
2900 37th St NW building 110
Show all (1)

Vyriad Financials and Metrics

Summary Metrics

Founding Date

2016

Vyriad total Funding

$24.4 m

Vyriad latest funding size

$24.4 m

Time since last funding

2 years ago
Vyriad's latest funding round in November 2019 was reported to be $24.4 m. In total, Vyriad has raised $24.4 m
Show all financial metrics

Vyriad Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Vyriad Online and Social Media Presence

Embed Graph

Vyriad News and Updates

Vyriad, Inc. Appoints Harry Hoffman To Its Board Of Directors

ROCHESTER, Minn., Aug. 24, 2021 /PRNewswire/ -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced the appointment of leading life sciences investor Harry Hoffman to the Company's board of directors....

Vyriad Expands Clinical Study of Oncolytic Virus Therapy in Bladder Cancer Patients

ROCHESTER, Minn., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Vyriad, Inc. announced today the addition of new clinical sites in its ongoing clinical study evaluating an intravesical oncolytic measles virus therapy in bladder cancer patients scheduled for radical cystectomy (bladder removal surgery). This c…

Vyriad Frequently Asked Questions

  • When was Vyriad founded?

    Vyriad was founded in 2016.

  • Who are Vyriad key executives?

    Vyriad's key executives are Stephen J. Russell, Edwin Kania and Kah-Whye Peng.

  • How many employees does Vyriad have?

    Vyriad has 36 employees.

  • Who are Vyriad competitors?

    Competitors of Vyriad include DNAtriX, Century Therapeutics and Dendreon.

  • Where is Vyriad headquarters?

    Vyriad headquarters is located at 2900 37th St NW building 110, Rochester.

  • Where are Vyriad offices?

    Vyriad has an office in Rochester.

  • How many offices does Vyriad have?

    Vyriad has 1 office.